Cambium Bio Ltd (CMB)

Currency in AUD
0.420
-0.015(-3.45%)
Closed·
CMB Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
CMB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4200.445
52 wk Range
0.1900.680
Key Statistics
Bid/Ask
0.42 / 0.445
Prev. Close
0.435
Open
0.44
Day's Range
0.42-0.445
52 wk Range
0.19-0.68
Volume
2K
Average Volume (3m)
13.37K
1-Year Change
10%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CMB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.570
Upside
+511.90%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Cambium Bio Ltd Company Profile

Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. Its lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus for wound healing indications. Cambium Bio Limited is based in Paddington, Australia.

Compare CMB to Peers and Sector

Metrics to compare
CMB
Peers
Sector
Relationship
P/E Ratio
0.0x−2.4x−0.5x
PEG Ratio
0.00−0.040.00
Price/Book
0.0x3.1x2.6x
Price / LTM Sales
0.0x8.5x3.3x
Upside (Analyst Target)
0.0%204.2%43.4%
Fair Value Upside
Unlock−3.9%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.570
(+511.90% Upside)

Earnings

Latest Release
Feb 28, 2023
EPS / Forecast
-0.01 / --
Revenue / Forecast
28.22K / --
EPS Revisions
Last 90 days

CMB Income Statement

FAQ

What Stock Exchange Does Cambium Bio Trade On?

Cambium Bio is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Cambium Bio?

The stock symbol for Cambium Bio is "CMB."

What Is the Cambium Bio Market Cap?

As of today, Cambium Bio market cap is 7.68M.

What Is Cambium Bio's Earnings Per Share (TTM)?

The Cambium Bio EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is CMB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cambium Bio Stock Split?

Cambium Bio has split 2 times.

How Many Employees Does Cambium Bio Have?

Cambium Bio has 0 employees.

What is the current trading status of Cambium Bio (CMB)?

As of 08 Aug 2025, Cambium Bio (CMB) is trading at a price of 0.42, with a previous close of 0.44. The stock has fluctuated within a day range of 0.42 to 0.45, while its 52-week range spans from 0.19 to 0.68.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.